3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
9
Li-Fraumeni Syndrome
1
Hamartoma Syndrome, Multiple
1
Endoscopic Subcutaneous Mastectomy
1
Cystic Fibrosis
1
Carcinoma, Ductal
1
Carcinoma in Situ
1
Breast Carcinoma In Situ
1
Interventions
toripalimab
1
durvalumab
1
advexin
1
Surveys and Questionnaires
1
Sampling Studies
1
Nivolumab
1
Mitomycin
1
Mastectomy, Subcutaneous
1
Magnetic Resonance Imaging
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cystoscopy
1
Cholecalciferol
1
Blood Specimen Collection
1
Biopsy
1
Aminolevulinic Acid
1
1-phenyl-3,3-dimethyltriazene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma in Situ
×
Mastectomy, Subcutaneous
×
Clear all
NCT02311959
2026-04-14
MAPAM-01
Institut Claudius Regaud
Phase 3
Completed
450 enrolled